… based on various in vitro and in vivo properties, including … Μoreover, apixaban retained
excellent factor Xa inhibitory … on sinus node, the heart's natural pacema er [101]; perfusion …

… However, experts do use early anticoagulation therapy for … ) like dabigatran, rivaroxaban,
apixaban, and edoxaban provide … Sanad II study (2021), an open-label, randomized controlled …

… She was continued on dual antiplatelet therapy (DAPT) with … Statins, aspirin, enoxaparin,
and rivaroxaban/apixaban have … trial, a phase 3, randomized, open-label study, no patients …

… A larger, multicenter, open-label trial assessed a similar … requiring anticoagulation or
antiplatelet therapy. The most commonly … Apixaban appears to have the least DDI potential since it …

… center study; and safety and efficacy of long-term open-label … and venous thrombosis in
consecutive hospitalized cirrhotic … in-vivo-like ex ovo hen's egg model of thrombosis, where 4-…

… and Sabraud's dextrose fluid were put into the chambers. … induce thrombus and
thrombocytopenia in in-vivo models. … fondaparinux, apixaban, or rivaroxaban may be used. …

… In AF, the upper chambers of the heart do not function correctly as a result of abnormal … ,
dabigatran or apixaban[27]. If the CHA2DS2-VASc score is 1, antithrombotic therapy may not be …

… trial, an open label active treatment extension was performed … A 1 year prospective-descriptive
study on consecutive … and function in vitro and vivo, illuminating epigenetic targets …

… patient was discharged with oral apixaban, Eliquis® (5 mg twice … and improvements in
sequencing techniques have enabled the … were included into the pragmatic open-label pilot trial. …